Nitisinone dosing regimens for the treatment of alkaptonuria

MA39918AUndetermined Publication Date: 2017-03-08SWEDISH ORPHAN BIOVITRUM INT

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39918
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-04-30
Filing Date: 2015-04-29
Publication Date: 2017-03-08

Application Information

Patent Timeline

30 Apr 2014

Priority

29 Apr 2015

Application

MA39918

08 Mar 2017

Publication

MA39918A

IPC: A61P3/00; A61K31/122

CPC: A61K31/122; A61P19/02; A61P3/00; A61K9/0053

Inventors: OLSSON Birgitta

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to nitisinone (2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3- cyclohexanedione) for use in the treatment of alkaptonuria, wherein nitisinone is administered in a dose of at least 4 mg per day. The invention also relates to a pharmaceutical composition comprising nitisinone for use in the treatment of alkaptonuria, wherein nitisinone is administered in a dose of at least 4 mg per day.

Need to check novelty before this filing date? Find Prior Art